US · Healthcare

GT Biopharma Inc (GTBP)

Biotechnology

GT Biopharma Inc (GTBP) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GTBP

P/E ratio

18.00

GT Biopharma Inc (GTBP) — FAQ

What is GTBP's P/E ratio?

The price-to-earnings (P/E) ratio for GT Biopharma Inc (GTBP) is 18.00 (data as of 2026-03-24).

Does GT Biopharma Inc pay a dividend?

Dividend yield is not available in the current snapshot for GT Biopharma Inc (GTBP). Check the MyAverix Finance app for the latest dividend data.

What sector is GT Biopharma Inc in?

GT Biopharma Inc (GTBP) is classified in the Healthcare sector (Biotechnology industry).

What exchange is GTBP listed on?

GTBP is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)